Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)
Phase 3
Completed
- Conditions
- Irritable Bowel Syndrome With Diarrhea
- Interventions
- Drug: PlaceboDrug: Rezular 15mgDrug: Rezular
- First Posted Date
- 2007-11-02
- Last Posted Date
- 2009-06-11
- Lead Sponsor
- AGI Therapeutics, Inc.
- Target Recruit Count
- 711
- Registration Number
- NCT00552565
- Locations
- 🇺🇸
PPD, Wilmington, North Carolina, United States
News
No news found